
Diacerein (50mg) + Methyl Sulfonyl Methane (250mg) + Glucosamine (750mg)
Active composition
+2 more active ingredients
Diacerein inhibits the action of interleukin-1, reducing inflammation and promoting cartilage repair.
Glucosamine stimulates the synthesis of glycosaminoglycans and proteoglycans, essential components of cartilage, promoting joint repair.
Medical applications
Jointolix 750mg/50mg/250mg Tablet is a combination pharmaceutical formulation containing Glucosamine sulfate 750mg, Diacerein 50mg, and Methyl Sulfonyl Methane (MSM) 250mg, designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint disorders. Glucosamine is a naturally occurring amino sugar that plays a crucial role in the synthesis of glycosaminoglycans and proteoglycans, essential components of cartilage, thereby promoting cartilage repair and maintenance. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and disease-modifying properties by inhibiting interleukin-1 beta, a key mediator in cartilage degradation and inflammation. Methyl Sulfonyl Methane is an organic sulfur compound that contributes to connective tissue repair and exhibits antioxidant and anti-inflammatory effects, further supporting joint function and reducing pain and stiffness. The synergistic action of these three active ingredients aids in improving joint mobility, reducing inflammation, and slowing disease progression. Jointolix is indicated for patients with mild to moderate osteoarthritis and other joint-related conditions requiring symptomatic relief and cartilage protection. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component, and potential interactions with other anti-inflammatory agents. Regular monitoring and adherence to prescribed dosages are essential for optimal therapeutic outcomes.
How to use Jointolix Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jointolix 750mg/50mg/250mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Jointolix 750mg/50mg/250mg Tablet. Please consult your doctor.
High Risk
Information regarding the use of Jointolix 750mg/50mg/250mg Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
It is not known whether Jointolix 750mg/50mg/250mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Jointolix 750mg/50mg/250mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Information regarding the use of Jointolix 750mg/50mg/250mg Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Jointolix 750mg/50mg/250mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Jointolix 750mg/50mg/250mg Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Jointolix 750mg/50mg/250mg Tablet

Glucosamine (750mg) + Diacerein (50mg) + Methyl Sulfonyl Methane (250mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Diacerein inhibits the action of interleukin-1, reducing inflammation and promoting cartilage repair.
Glucosamine stimulates the synthesis of glycosaminoglycans and proteoglycans, essential components of cartilage, promoting joint repair.
Medical applications
Jointolix 750mg/50mg/250mg Tablet is a combination pharmaceutical formulation containing Glucosamine sulfate 750mg, Diacerein 50mg, and Methyl Sulfonyl Methane (MSM) 250mg, designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint disorders. Glucosamine is a naturally occurring amino sugar that plays a crucial role in the synthesis of glycosaminoglycans and proteoglycans, essential components of cartilage, thereby promoting cartilage repair and maintenance. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and disease-modifying properties by inhibiting interleukin-1 beta, a key mediator in cartilage degradation and inflammation. Methyl Sulfonyl Methane is an organic sulfur compound that contributes to connective tissue repair and exhibits antioxidant and anti-inflammatory effects, further supporting joint function and reducing pain and stiffness. The synergistic action of these three active ingredients aids in improving joint mobility, reducing inflammation, and slowing disease progression. Jointolix is indicated for patients with mild to moderate osteoarthritis and other joint-related conditions requiring symptomatic relief and cartilage protection. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component, and potential interactions with other anti-inflammatory agents. Regular monitoring and adherence to prescribed dosages are essential for optimal therapeutic outcomes.
How to use Jointolix Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jointolix 750mg/50mg/250mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Jointolix 750mg/50mg/250mg Tablet. Please consult your doctor.
High Risk
Information regarding the use of Jointolix 750mg/50mg/250mg Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
It is not known whether Jointolix 750mg/50mg/250mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Jointolix 750mg/50mg/250mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Information regarding the use of Jointolix 750mg/50mg/250mg Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Jointolix 750mg/50mg/250mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Jointolix 750mg/50mg/250mg Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Jointolix 750mg/50mg/250mg Tablet















